BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 21598098)

  • 1. Neuroprotective and neurotoxic signaling by the prion protein.
    Resenberger UK; Winklhofer KF; Tatzelt J
    Top Curr Chem; 2011; 305():101-19. PubMed ID: 21598098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular prion protein mediates toxic signaling of amyloid beta.
    Resenberger UK; Winklhofer KF; Tatzelt J
    Neurodegener Dis; 2012; 10(1-4):298-300. PubMed ID: 22156337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo neurotoxicity of prion protein oligomers.
    Simoneau S; Rezaei H; Salès N; Kaiser-Schulz G; Lefebvre-Roque M; Vidal C; Fournier JG; Comte J; Wopfner F; Grosclaude J; Schätzl H; Lasmézas CI
    PLoS Pathog; 2007 Aug; 3(8):e125. PubMed ID: 17784787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous prion protein conversion is required for prion-induced neuritic alterations and neuronal death.
    Cronier S; Carimalo J; Schaeffer B; Jaumain E; Béringue V; Miquel MC; Laude H; Peyrin JM
    FASEB J; 2012 Sep; 26(9):3854-61. PubMed ID: 22661006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prion encephalopathies of animals and humans.
    Prusiner SB
    Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible role for Ca2+ in the pathophysiology of the prion protein?
    Peggion C; Bertoli A; Sorgato MC
    Biofactors; 2011; 37(3):241-9. PubMed ID: 21698700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis of cerebral neurodegeneration in prion diseases.
    Tatzelt J; Schätzl HM
    FEBS J; 2007 Feb; 274(3):606-11. PubMed ID: 17288549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration.
    Costanzo M; Zurzolo C
    Biochem J; 2013 May; 452(1):1-17. PubMed ID: 23614720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expansion of the octarepeat domain alters the misfolding pathway but not the folding pathway of the prion protein.
    Leliveld SR; Stitz L; Korth C
    Biochemistry; 2008 Jun; 47(23):6267-78. PubMed ID: 18473442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotoxicity of the putative transmembrane domain of the prion protein.
    Haïk S; Peyrin JM; Lins L; Rosseneu MY; Brasseur R; Langeveld JP; Tagliavini F; Deslys JP; Lasmézas C; Dormont D
    Neurobiol Dis; 2000 Dec; 7(6 Pt B):644-56. PubMed ID: 11114262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prions can infect primary cultured neurons and astrocytes and promote neuronal cell death.
    Cronier S; Laude H; Peyrin JM
    Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12271-6. PubMed ID: 15302929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prion protein unstructured N-terminal region is a broad-spectrum molecular sensor with diverse and contrasting potential functions.
    Béland M; Roucou X
    J Neurochem; 2012 Mar; 120(6):853-68. PubMed ID: 22145935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Traffic of prion protein between different compartments on the neuronal surface, and the propagation of prion disease.
    Morris RJ; Parkyn CJ; Jen A
    FEBS Lett; 2006 Oct; 580(23):5565-71. PubMed ID: 16884720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prion neurotoxicity: insights from prion protein mutants.
    Solomon IH; Schepker JA; Harris DA
    Curr Issues Mol Biol; 2010; 12(2):51-61. PubMed ID: 19767650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prion protein and copper: a mysterious relationship].
    Rachidi W; Riondel J; McMahon HM; Favier A
    Pathol Biol (Paris); 2005 May; 53(4):244-50. PubMed ID: 15850959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenetic investigations of prion diseases of humans and animals.
    Prusiner SB
    Philos Trans R Soc Lond B Biol Sci; 1993 Feb; 339(1288):239-54. PubMed ID: 8097053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein misfolding and neurodegeneration.
    Soto C; Estrada LD
    Arch Neurol; 2008 Feb; 65(2):184-9. PubMed ID: 18268186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of prion-induced neurodegeneration.
    Saá P; Harris DA; Cervenakova L
    Expert Rev Mol Med; 2016 Apr; 18():e5. PubMed ID: 27055367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generalization of the prion hypothesis to other neurodegenerative diseases: an imperfect fit.
    Guest WC; Silverman JM; Pokrishevsky E; O'Neill MA; Grad LI; Cashman NR
    J Toxicol Environ Health A; 2011; 74(22-24):1433-59. PubMed ID: 22043906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sc237 hamster PrPSc and Sc237-derived mouse PrPSc generated by interspecies in vitro amplification exhibit distinct pathological and biochemical properties in tga20 transgenic mice.
    Yoshioka M; Imamura M; Okada H; Shimozaki N; Murayama Y; Yokoyama T; Mohri S
    Microbiol Immunol; 2011 May; 55(5):331-40. PubMed ID: 21362027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.